SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Ron Flanigan who wrote (5870)10/12/1998 4:31:00 PM
From: Tokyo VD  Read Replies (1) | Respond to of 9523
 
Ron,

While waxing poetic, you forgot that the original discussion was a declining sales figures for Viagra. I offered to intellectually discuss the market for the product. Instead, you chose to tell me of your forecast for the quarter.

Thank you for your opinion.

Tokyo



To: Ron Flanigan who wrote (5870)10/13/1998 4:13:00 PM
From: Tokyo VD  Read Replies (2) | Respond to of 9523
 
Ron,

I guess your $0.03 upside estimate was way off. Pfizer reported $0.51 which is $0.06 below the First Call estimate.

Viagra sales were $141 million in Q3, also well below estimates of $250-270 million.

Guess you and the other optimists for Viagra had difficulty forecasting sales of the "miracle" drug.

Tokyo


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News